Final Overall Survival (Os) Analysis of Cou-Aa-302, a Randomized Phase 3 Study of Abiraterone Acetate (Aa) in Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients (Pts) Without Prior Chemotherapy
2014; Elsevier BV; Volume: 25; Linguagem: Inglês
10.1093/annonc/mdu336.1
ISSN1569-8041
AutoresCharles J. Ryan, M.R. Smith, Karim Fizazi, K. Miller, Peter Mulders, Cora N. Sternberg, Farid Saad, Thomas W. Griffin, Peter De Porre, Y.C. Park, J. Li, Thian Kheoh, Vahid Naini, A. Molina, Dana E. Rathkopf,
Tópico(s)Radiopharmaceutical Chemistry and Applications
Referência(s)